25 XP   0   0   10

Evolent Health Inc
Buy, Hold or Sell?

Let's analyse Evolent together

PenkeI guess you are interested in Evolent Health Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Evolent Health Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Evolent Health Inc

I send you an email if I find something interesting about Evolent Health Inc.

Quick analysis of Evolent (30 sec.)










What can you expect buying and holding a share of Evolent? (30 sec.)

How much money do you get?

How much money do you get?
$0.17
When do you have the money?
1 year
How often do you get paid?
27.5%

What is your share worth?

Current worth
$9.37
Expected worth in 1 year
$11.20
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$1.99
Return On Investment
7.0%

For what price can you sell your share?

Current Price per Share
$28.32
Expected price per share
$23.10 - $29.46
How sure are you?
50%

1. Valuation of Evolent (5 min.)




Live pricePrice per Share (EOD)

$28.32

Intrinsic Value Per Share

$27.36 - $32.86

Total Value Per Share

$36.73 - $42.24

2. Growth of Evolent (5 min.)




Is Evolent growing?

Current yearPrevious yearGrowGrow %
How rich?$1b$734.9m$359.7m32.9%

How much money is Evolent making?

Current yearPrevious yearGrowGrow %
Making money-$28.2m-$4.6m-$23.5m-83.5%
Net Profit Margin-5.7%-1.4%--

How much money comes from the company's main activities?

3. Financial Health of Evolent (5 min.)




4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  


Richest
#10 / 120

Most Revenue
#6 / 120

Most Profit
#104 / 120

What can you expect buying and holding a share of Evolent? (5 min.)

Welcome investor! Evolent's management wants to use your money to grow the business. In return you get a share of Evolent.

What can you expect buying and holding a share of Evolent?

First you should know what it really means to hold a share of Evolent. And how you can make/lose money.

Speculation

The Price per Share of Evolent is $28.32. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Evolent.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Evolent, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $9.37. Based on the TTM, the Book Value Change Per Share is $0.46 per quarter. Based on the YOY, the Book Value Change Per Share is $0.36 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Evolent.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.29-1.0%-0.29-1.0%-0.04-0.1%-0.36-1.3%-0.11-0.4%
Usd Book Value Change Per Share-0.25-0.9%0.461.6%0.361.3%-0.05-0.2%0.220.8%
Usd Dividend Per Share0.050.2%0.040.1%0.551.9%0.120.4%0.060.2%
Usd Total Gains Per Share-0.20-0.7%0.501.8%0.923.2%0.070.2%0.281.0%
Usd Price Per Share33.03-30.75-31.76-21.39-17.65-
Price to Earnings Ratio-28.15--26.88-12.24--22.91--24.56-
Price-to-Total Gains Ratio-161.94-23.77-90.74--128.21--212.98-
Price to Book Ratio3.52-3.20-5.06-3.10-2.40-
Price-to-Total Gains Ratio-161.94-23.77-90.74--128.21--212.98-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share28.32
Number of shares35
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.12
Usd Book Value Change Per Share0.46-0.05
Usd Total Gains Per Share0.500.07
Gains per Quarter (35 shares)17.452.34
Gains per Year (35 shares)69.789.34
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
16646017-7-1
21212813034-158
31719220050-2217
42325627067-3026
52932034084-3735
635384410101-4544
740448480118-5253
846512550135-6062
952576620151-6771
1058640690168-7580

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%3.037.00.07.5%3.037.01.07.3%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%7.013.00.035.0%13.024.03.032.5%14.024.03.034.1%
Dividend per Share4.00.00.0100.0%11.00.01.091.7%11.00.09.055.0%11.00.029.027.5%11.00.030.026.8%
Total Gains per Share2.02.00.050.0%6.06.00.050.0%7.013.00.035.0%13.024.03.032.5%14.024.03.034.1%

Fundamentals of Evolent

About Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Fundamental data was last updated by Penke on 2024-04-13 13:48:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Evolent Health Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Evolent earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Evolent to the Health Information Services industry mean.
  • A Net Profit Margin of -6.0% means that $-0.06 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Evolent Health Inc:

  • The MRQ is -6.0%. The company is making a loss. -1
  • The TTM is -5.7%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-6.0%TTM-5.7%-0.3%
TTM-5.7%YOY-1.4%-4.4%
TTM-5.7%5Y-15.8%+10.1%
5Y-15.8%10Y64.7%-80.6%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.0%-21.3%+15.3%
TTM-5.7%-20.1%+14.4%
YOY-1.4%-29.8%+28.4%
5Y-15.8%-36.1%+20.3%
10Y64.7%-42.2%+106.9%
1.1.2. Return on Assets

Shows how efficient Evolent is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Evolent to the Health Information Services industry mean.
  • -1.2% Return on Assets means that Evolent generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Evolent Health Inc:

  • The MRQ is -1.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.2%TTM-1.1%-0.2%
TTM-1.1%YOY-0.3%-0.8%
TTM-1.1%5Y-2.7%+1.6%
5Y-2.7%10Y-3.0%+0.4%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.2%-6.5%+5.3%
TTM-1.1%-6.0%+4.9%
YOY-0.3%-5.4%+5.1%
5Y-2.7%-5.3%+2.6%
10Y-3.0%-7.4%+4.4%
1.1.3. Return on Equity

Shows how efficient Evolent is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Evolent to the Health Information Services industry mean.
  • -3.1% Return on Equity means Evolent generated $-0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Evolent Health Inc:

  • The MRQ is -3.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.1%TTM-2.6%-0.5%
TTM-2.6%YOY-0.7%-1.9%
TTM-2.6%5Y-4.9%+2.3%
5Y-4.9%10Y-9.2%+4.2%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.1%-6.8%+3.7%
TTM-2.6%-6.8%+4.2%
YOY-0.7%-6.7%+6.0%
5Y-4.9%-8.4%+3.5%
10Y-9.2%-9.6%+0.4%

1.2. Operating Efficiency of Evolent Health Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Evolent is operating .

  • Measures how much profit Evolent makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Evolent to the Health Information Services industry mean.
  • An Operating Margin of -0.5% means the company generated $-0.01  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Evolent Health Inc:

  • The MRQ is -0.5%. The company is operating very inefficient. -2
  • The TTM is -0.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-0.5%TTM-0.6%+0.1%
TTM-0.6%YOY-1.0%+0.4%
TTM-0.6%5Y-3.5%+2.9%
5Y-3.5%10Y-106.2%+102.7%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.5%-22.7%+22.2%
TTM-0.6%-16.4%+15.8%
YOY-1.0%-22.8%+21.8%
5Y-3.5%-18.4%+14.9%
10Y-106.2%-31.6%-74.6%
1.2.2. Operating Ratio

Measures how efficient Evolent is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 1.02 means that the operating costs are $1.02 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Evolent Health Inc:

  • The MRQ is 1.017. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.010. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.017TTM1.010+0.007
TTM1.010YOY1.013-0.003
TTM1.0105Y1.051-0.041
5Y1.05110Y1.094-0.043
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0171.370-0.353
TTM1.0101.385-0.375
YOY1.0131.389-0.376
5Y1.0511.398-0.347
10Y1.0941.349-0.255

1.3. Liquidity of Evolent Health Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Evolent is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 1.01 means the company has $1.01 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Evolent Health Inc:

  • The MRQ is 1.014. The company is just able to pay all its short-term debts.
  • The TTM is 3.112. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ1.014TTM3.112-2.098
TTM3.112YOY1.145+1.967
TTM3.1125Y2.083+1.029
5Y2.08310Y2.158-0.074
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0141.811-0.797
TTM3.1121.820+1.292
YOY1.1452.055-0.910
5Y2.0832.589-0.506
10Y2.1582.589-0.431
1.3.2. Quick Ratio

Measures if Evolent is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Evolent to the Health Information Services industry mean.
  • A Quick Ratio of 0.97 means the company can pay off $0.97 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Evolent Health Inc:

  • The MRQ is 0.969. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 3.050. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.969TTM3.050-2.081
TTM3.050YOY1.067+1.983
TTM3.0505Y1.784+1.266
5Y1.78410Y3.292-1.508
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9691.152-0.183
TTM3.0501.241+1.809
YOY1.0671.723-0.656
5Y1.7842.117-0.333
10Y3.2922.107+1.185

1.4. Solvency of Evolent Health Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Evolent assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Evolent to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.60 means that Evolent assets are financed with 60.2% credit (debt) and the remaining percentage (100% - 60.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Evolent Health Inc:

  • The MRQ is 0.602. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.586. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.602TTM0.586+0.015
TTM0.586YOY0.528+0.058
TTM0.5865Y0.492+0.094
5Y0.49210Y0.383+0.109
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6020.379+0.223
TTM0.5860.381+0.205
YOY0.5280.399+0.129
5Y0.4920.411+0.081
10Y0.3830.453-0.070
1.4.2. Debt to Equity Ratio

Measures if Evolent is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Evolent to the Health Information Services industry mean.
  • A Debt to Equity ratio of 151.0% means that company has $1.51 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Evolent Health Inc:

  • The MRQ is 1.510. The company is just able to pay all its debts with equity.
  • The TTM is 1.419. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.510TTM1.419+0.091
TTM1.419YOY1.122+0.297
TTM1.4195Y1.029+0.390
5Y1.02910Y0.865+0.164
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5100.584+0.926
TTM1.4190.575+0.844
YOY1.1220.607+0.515
5Y1.0290.709+0.320
10Y0.8650.616+0.249

2. Market Valuation of Evolent Health Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Evolent generates.

  • Above 15 is considered overpriced but always compare Evolent to the Health Information Services industry mean.
  • A PE ratio of -28.15 means the investor is paying $-28.15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Evolent Health Inc:

  • The EOD is -24.135. Based on the earnings, the company is expensive. -2
  • The MRQ is -28.149. Based on the earnings, the company is expensive. -2
  • The TTM is -26.881. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-24.135MRQ-28.149+4.014
MRQ-28.149TTM-26.881-1.267
TTM-26.881YOY12.236-39.118
TTM-26.8815Y-22.912-3.969
5Y-22.91210Y-24.555+1.643
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-24.135-1.331-22.804
MRQ-28.149-2.188-25.961
TTM-26.881-2.131-24.750
YOY12.236-3.487+15.723
5Y-22.912-4.987-17.925
10Y-24.555-4.494-20.061
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Evolent Health Inc:

  • The EOD is 9.677. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 11.286. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -41.974. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD9.677MRQ11.286-1.609
MRQ11.286TTM-41.974+53.260
TTM-41.974YOY34.726-76.700
TTM-41.9745Y-1.202-40.772
5Y-1.20210Y6.138-7.340
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD9.677-1.376+11.053
MRQ11.286-1.754+13.040
TTM-41.974-2.377-39.597
YOY34.726-5.605+40.331
5Y-1.202-3.847+2.645
10Y6.138-3.463+9.601
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Evolent is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 3.52 means the investor is paying $3.52 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Evolent Health Inc:

  • The EOD is 3.021. Based on the equity, the company is fair priced.
  • The MRQ is 3.523. Based on the equity, the company is fair priced.
  • The TTM is 3.201. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.021MRQ3.523-0.502
MRQ3.523TTM3.201+0.322
TTM3.201YOY5.056-1.855
TTM3.2015Y3.099+0.102
5Y3.09910Y2.395+0.704
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD3.0211.760+1.261
MRQ3.5231.837+1.686
TTM3.2011.943+1.258
YOY5.0562.978+2.078
5Y3.0993.997-0.898
10Y2.3954.198-1.803
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Evolent Health Inc.

3.1. Institutions holding Evolent Health Inc

Institutions are holding 112.026% of the shares of Evolent Health Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31FMR Inc11.31830.032712890729-3609017-21.8732
2023-12-31Vanguard Group Inc9.50140.0078108213312266912.1397
2023-12-31BlackRock Inc7.39720.007184248025860597.4764
2023-12-31Wellington Management Company LLP7.29910.05128313157407395996.1021
2023-12-31JPMorgan Chase & Co5.19580.01885917684-130802-2.1626
2023-12-31Rock Springs Capital Management LP3.4773.21993960000950002.458
2023-12-31William Blair Investment Management, LLC3.31760.36323778453115600444.0811
2023-12-31Engaged Capital LLC2.863615.7792326145842864815.1315
2023-12-31Blair William & Co2.66930.342230401571891506.6345
2023-12-31Granahan Investment Management Inc..2.54913.16732903191-50819-1.7203
2023-12-31Orbimed Advisors, LLC2.41151.81172746532-149100-5.1491
2023-12-31Eventide Asset Management, LLC2.3171.4227263894660.0002
2023-12-31RA Capital Management, LLC2.23821.31512549132-187548-6.8531
2023-12-31State Street Corporation2.16520.00424659731286195.5028
2023-12-31Bellevue Group AG2.0871.2012376992-1300123-35.3571
2023-12-31Geode Capital Management, LLC2.07690.008223654161479676.6728
2023-09-30Holocene Advisors, LP2.00810.2727228709933847417.3699
2023-12-31Farallon Capital Management, L.L.C.1.90.3548216390926300013.8355
2023-12-31Amvescap Plc.1.82140.016320744481422717.3632
2023-12-31Hood River Capital Management LLC1.81751.880220700331624218.5144
Total 76.431231.276187049442+2510860+2.9%

3.2. Funds holding Evolent Health Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.96940.00743381933-9654-0.2846
2023-12-31Vanguard Health Care Inv2.94280.238533516191634005.1251
2024-02-29Vanguard Small Cap Index2.47150.06792814807260330.9335
2024-03-28iShares Russell 2000 ETF2.41670.1378275238884570.3082
2023-11-30Bellevue Healthcare Ord1.83796.6142209326151331532.4894
2023-12-31Worldwide Healthcare Ord1.74812.6286199091500
2023-12-31Vanguard Explorer Inv1.54010.2709175402417540240
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.49260.05651699955-7164-0.4197
2024-02-29JPMorgan Small Cap Growth A1.46091.39351663907-1513-0.0908
2024-02-29Fidelity Select Health Care1.40480.68541600000-178600-10.0416
2024-02-29Vanguard Small Cap Growth Index Inv1.38380.15311576086194091.2468
2024-02-29Fidelity Select Medical Tech and Devcs1.35220.89031540000-213500-12.1756
2024-02-29JPM Global Healthcare C (acc) USD1.34811.11971535407-183461-10.6734
2023-12-31Eventide Gilead N1.1761.1561133933900
2024-02-29CS (Lux) Digital Health Equity SB USD1.16782.89561330000-60000-4.3165
2023-12-31Eventide Healthcare & Life Sciences I1.14042.5737129880500
2024-01-31Fidelity Small Cap Index0.98010.13241116314179961.6385
2023-12-31Hood River Small-Cap Growth Instl0.9141.8376104101713863115.3627
2024-02-29Fidelity Advisor Health Care I0.8780.68141000000-123226-10.9707
2024-01-31Fidelity Puritan0.85750.101497660000
Total 31.482723.64235856377+1864147+5.2%

3.3. Insider Transactions

Insiders are holding 4.166% of the shares of Evolent Health Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-05Seth BlackleySELL14100026.54
2023-11-15Daniel Joseph MccarthySELL1100030
2023-06-28Seth BlackleySELL3301130.78
2023-06-16Seth BlackleySELL209830.16
2023-06-14Cheryl ScottSELL236530.01
2023-06-12Daniel Joseph MccarthySELL100031.44
2023-06-12Diane HolderSELL1200031.26
2023-06-01Frank J WilliamsSELL11000029.52
2023-05-01Frank J WilliamsSELL11000036.29

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Evolent Health Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.2490.457-155%0.364-169%-0.053-79%0.219-214%
Book Value Per Share--9.3759.612-2%6.453+45%7.450+26%6.905+36%
Current Ratio--1.0143.112-67%1.145-11%2.083-51%2.158-53%
Debt To Asset Ratio--0.6020.586+3%0.528+14%0.492+22%0.383+57%
Debt To Equity Ratio--1.5101.419+6%1.122+35%1.029+47%0.865+75%
Dividend Per Share--0.0450.041+10%0.552-92%0.120-62%0.060-25%
Eps---0.293-0.295+0%-0.042-86%-0.363+24%-0.108-63%
Free Cash Flow Per Share--0.7320.250+193%-0.110+115%-0.020+103%-0.054+107%
Free Cash Flow To Equity Per Share---0.0090.867-101%0.179-105%0.127-107%0.243-104%
Gross Profit Margin--1047.226262.557+299%1.772+59013%53.770+1848%27.385+3724%
Intrinsic Value_10Y_max--32.862--------
Intrinsic Value_10Y_min--27.357--------
Intrinsic Value_1Y_max--0.672--------
Intrinsic Value_1Y_min--0.659--------
Intrinsic Value_3Y_max--4.017--------
Intrinsic Value_3Y_min--3.794--------
Intrinsic Value_5Y_max--9.770--------
Intrinsic Value_5Y_min--8.896--------
Market Cap3225449760.000-17%3761885790.0003502494482.500+7%3616672215.000+4%2436057377.000+54%2010012137.250+87%
Net Profit Margin---0.060-0.057-5%-0.014-77%-0.158+164%0.647-109%
Operating Margin---0.005-0.006+20%-0.010+97%-0.035+574%-1.062+20463%
Operating Ratio--1.0171.010+1%1.013+0%1.051-3%1.094-7%
Pb Ratio3.021-17%3.5233.201+10%5.056-30%3.099+14%2.395+47%
Pe Ratio-24.135+14%-28.149-26.881-5%12.236-330%-22.912-19%-24.555-13%
Price Per Share28.320-17%33.03030.753+7%31.755+4%21.389+54%17.648+87%
Price To Free Cash Flow Ratio9.677-17%11.286-41.974+472%34.726-67%-1.202+111%6.138+84%
Price To Total Gains Ratio-138.848+14%-161.94123.774-781%90.738-278%-128.213-21%-212.977+32%
Quick Ratio--0.9693.050-68%1.067-9%1.784-46%3.292-71%
Return On Assets---0.012-0.011-14%-0.003-76%-0.027+113%-0.030+141%
Return On Equity---0.031-0.026-17%-0.007-79%-0.049+58%-0.092+193%
Total Gains Per Share---0.2040.498-141%0.916-122%0.067-406%0.279-173%
Usd Book Value--1067701000.0001094689000.000-2%734963000.000+45%848538550.000+26%786422750.000+36%
Usd Book Value Change Per Share---0.2490.457-155%0.364-169%-0.053-79%0.219-214%
Usd Book Value Per Share--9.3759.612-2%6.453+45%7.450+26%6.905+36%
Usd Dividend Per Share--0.0450.041+10%0.552-92%0.120-62%0.060-25%
Usd Eps---0.293-0.295+0%-0.042-86%-0.363+24%-0.108-63%
Usd Free Cash Flow--83329000.00028459250.000+193%-12478500.000+115%-2309500.000+103%-5968150.000+107%
Usd Free Cash Flow Per Share--0.7320.250+193%-0.110+115%-0.020+103%-0.054+107%
Usd Free Cash Flow To Equity Per Share---0.0090.867-101%0.179-105%0.127-107%0.243-104%
Usd Market Cap3225449760.000-17%3761885790.0003502494482.500+7%3616672215.000+4%2436057377.000+54%2010012137.250+87%
Usd Price Per Share28.320-17%33.03030.753+7%31.755+4%21.389+54%17.648+87%
Usd Profit---33411000.000-28260000.000-15%-4675250.000-86%-40227950.000+20%-19615700.000-41%
Usd Revenue--556055000.000490974000.000+13%338003250.000+65%304634100.000+83%191594150.000+190%
Usd Total Gains Per Share---0.2040.498-141%0.916-122%0.067-406%0.279-173%
 EOD+4 -4MRQTTM+14 -22YOY+15 -215Y+20 -1610Y+17 -19

4.2. Fundamental Score

Let's check the fundamental score of Evolent Health Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-24.135
Price to Book Ratio (EOD)Between0-13.021
Net Profit Margin (MRQ)Greater than0-0.060
Operating Margin (MRQ)Greater than0-0.005
Quick Ratio (MRQ)Greater than10.969
Current Ratio (MRQ)Greater than11.014
Debt to Asset Ratio (MRQ)Less than10.602
Debt to Equity Ratio (MRQ)Less than11.510
Return on Equity (MRQ)Greater than0.15-0.031
Return on Assets (MRQ)Greater than0.05-0.012
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of Evolent Health Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.474
Ma 20Greater thanMa 5030.247
Ma 50Greater thanMa 10031.802
Ma 100Greater thanMa 20031.239
OpenGreater thanClose28.970
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets2,680,308
Total Liabilities1,612,607
Total Stockholder Equity1,067,701
 As reported
Total Liabilities 1,612,607
Total Stockholder Equity+ 1,067,701
Total Assets = 2,680,308

Assets

Total Assets2,680,308
Total Current Assets683,673
Long-term Assets1,996,635
Total Current Assets
Cash And Cash Equivalents 192,825
Short-term Investments 13,768
Net Receivables 446,749
Other Current Assets 30,331
Total Current Assets  (as reported)683,673
Total Current Assets  (calculated)683,673
+/-0
Long-term Assets
Property Plant Equipment 90,177
Goodwill 1,116,542
Long Term Investments 4,895
Intangible Assets 752,009
Other Assets 33,012
Long-term Assets  (as reported)1,996,635
Long-term Assets  (calculated)1,996,635
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities674,242
Long-term Liabilities938,365
Total Stockholder Equity1,067,701
Total Current Liabilities
Short-term Debt 9,738
Accounts payable 48,246
Other Current Liabilities 610,282
Total Current Liabilities  (as reported)674,242
Total Current Liabilities  (calculated)668,266
+/- 5,976
Long-term Liabilities
Long term Debt 597,049
Capital Lease Obligations 47,747
Long-term Liabilities Other 3,637
Long-term Liabilities  (as reported)938,365
Long-term Liabilities  (calculated)648,433
+/- 289,932
Total Stockholder Equity
Common Stock1,154
Retained Earnings -719,194
Other Stockholders Equity 1,608,571
Total Stockholder Equity (as reported)1,067,701
Total Stockholder Equity (calculated)890,531
+/- 177,170
Other
Capital Stock1,154
Cash and Short Term Investments 192,825
Common Stock Shares Outstanding 113,588
Current Deferred Revenue5,976
Liabilities and Stockholders Equity 2,680,308
Net Debt 451,971
Net Invested Capital 1,664,750
Net Working Capital 9,431
Property Plant and Equipment Gross 248,746
Short Long Term Debt Total 644,796



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
> Total Assets 
101,975
0
0
0
38,277
76,434
1,039,837
1,056,181
1,015,514
860,063
852,801
851,280
1,199,839
1,154,446
1,138,352
1,299,030
1,312,697
1,306,310
1,321,620
1,322,676
1,722,281
1,629,374
1,652,256
1,713,901
1,498,015
1,451,754
1,270,134
1,391,789
1,370,185
1,305,584
1,293,367
1,253,525
1,419,458
1,339,149
1,303,912
1,759,182
1,817,293
2,589,459
2,646,831
2,669,615
2,680,308
2,680,3082,669,6152,646,8312,589,4591,817,2931,759,1821,303,9121,339,1491,419,4581,253,5251,293,3671,305,5841,370,1851,391,7891,270,1341,451,7541,498,0151,713,9011,652,2561,629,3741,722,2811,322,6761,321,6201,306,3101,312,6971,299,0301,138,3521,154,4461,199,839851,280852,801860,0631,015,5141,056,1811,039,83776,43438,277000101,975
   > Total Current Assets 
0
0
0
0
1,074
46,692
251,640
246,221
184,463
167,566
170,557
191,429
264,966
217,538
192,620
352,329
378,182
337,279
353,254
348,591
487,966
321,186
240,864
308,012
228,801
258,473
274,658
548,545
546,134
508,310
505,552
478,196
523,960
463,388
423,145
393,774
478,054
475,972
576,699
638,798
683,673
683,673638,798576,699475,972478,054393,774423,145463,388523,960478,196505,552508,310546,134548,545274,658258,473228,801308,012240,864321,186487,966348,591353,254337,279378,182352,329192,620217,538264,966191,429170,557167,566184,463246,221251,64046,6921,0740000
       Cash And Cash Equivalents 
67,891
0
0
0
15,134
12,591
219,367
208,157
145,726
111,292
105,138
109,777
134,563
104,295
99,975
287,143
238,433
200,316
197,983
221,837
228,320
170,817
92,821
96,734
101,008
67,944
98,272
370,514
340,490
236,032
207,273
252,496
266,280
210,158
193,070
156,756
188,200
157,519
142,530
184,536
192,825
192,825184,536142,530157,519188,200156,756193,070210,158266,280252,496207,273236,032340,490370,51498,27267,944101,00896,73492,821170,817228,320221,837197,983200,316238,433287,14399,975104,295134,563109,777105,138111,292145,726208,157219,36712,59115,13400067,891
       Short-term Investments 
500
0
0
0
29,889
12,003
4,397
2,023
9,445
20,096
27,577
49,693
44,341
33,684
24,027
5,070
62,398
711
712
712
818
1,319
812
3,815
1,807
1,413
834
4,677
3,858
53,479
17,742
16,509
88,662
39,647
74,377
25,057
14,492
34,451
47,477
23,208
13,768
13,76823,20847,47734,45114,49225,05774,37739,64788,66216,50917,74253,4793,8584,6778341,4131,8073,8158121,31981871271271162,3985,07024,02733,68444,34149,69327,57720,0969,4452,0234,39712,00329,889000500
       Net Receivables 
0
0
0
0
20,381
13,824
24,039
30,541
20,381
25,216
30,337
21,986
40,635
44,638
45,804
43,972
68,947
16,000
12,000
6,000
82,310
66,908
72,566
76,239
77,418
109,258
98,185
95,988
126,315
185,103
242,505
175,226
130,604
179,270
118,525
187,633
254,684
279,261
359,924
394,232
446,749
446,749394,232359,924279,261254,684187,633118,525179,270130,604175,226242,505185,103126,31595,98898,185109,25877,41876,23972,56666,90882,3106,00012,00016,00068,94743,97245,80444,63840,63521,98630,33725,21620,38130,54124,03913,82420,3810000
       Inventory 
0
0
0
0
0
0
-24,039
0
-20,381
-25,216
-30,337
-21,986
-40,635
0
0
-43,972
-3,262
36,757
57,054
45,722
78,513
-8,952
-120,229
0
-150,086
-114,531
-42,532
-435,055
-445,098
0
-418,641
-398,463
-308,222
0
-224,232
-306,327
-415,926
-402,329
-437,385
23,208
0
023,208-437,385-402,329-415,926-306,327-224,2320-308,222-398,463-418,6410-445,098-435,055-42,532-114,531-150,0860-120,229-8,95278,51345,72257,05436,757-3,262-43,97200-40,635-21,986-30,337-25,216-20,3810-24,039000000
   > Long-term Assets 
0
0
0
0
37,203
29,742
777,073
809,960
816,673
665,254
649,352
622,492
885,492
936,908
945,732
877,833
869,447
878,109
872,101
865,894
1,113,170
1,120,354
1,411,392
1,405,889
1,269,214
1,193,281
654,515
843,244
824,051
797,274
787,815
775,329
895,498
875,761
880,767
1,365,408
1,339,239
2,113,487
2,070,132
2,030,817
1,996,635
1,996,6352,030,8172,070,1322,113,4871,339,2391,365,408880,767875,761895,498775,329787,815797,274824,051843,244654,5151,193,2811,269,2141,405,8891,411,3921,120,3541,113,170865,894872,101878,109869,447877,833945,732936,908885,492622,492649,352665,254816,673809,960777,07329,74237,2030000
       Property Plant Equipment 
14,291
0
0
0
22,774
24,102
8,463
10,755
12,796
15,537
18,468
21,123
31,179
35,459
40,194
46,930
50,922
60,430
64,630
68,692
73,628
141,234
156,929
158,932
157,328
148,846
154,668
148,312
144,039
138,125
134,900
131,692
131,568
131,362
143,500
145,341
136,901
133,014
110,996
97,308
90,177
90,17797,308110,996133,014136,901145,341143,500131,362131,568131,692134,900138,125144,039148,312154,668148,846157,328158,932156,929141,23473,62868,69264,63060,43050,92246,93040,19435,45931,17921,12318,46815,53712,79610,7558,46324,10222,77400014,291
       Goodwill 
0
0
0
0
608,903
0
608,903
608,903
608,903
459,703
459,703
459,703
626,569
627,204
628,653
628,341
628,186
635,246
635,282
635,088
768,124
770,334
772,164
771,887
572,064
569,797
354,695
354,722
354,734
349,022
349,009
349,010
426,297
426,274
426,228
722,790
722,774
1,117,945
1,117,556
1,117,543
1,116,542
1,116,5421,117,5431,117,5561,117,945722,774722,790426,228426,274426,297349,010349,009349,022354,734354,722354,695569,797572,064771,887772,164770,334768,124635,088635,282635,246628,186628,341628,653627,204626,569459,703459,703459,703608,903608,903608,9030608,9030000
       Long Term Investments 
0
0
0
0
37,203
0
0
22,048
44,618
33,879
27,193
2,538
2,159
1,636
1,081
712
1,531
5,521
4,246
5,672
16,286
17,931
72,251
70,623
139,369
92,940
116,289
19,315
17,417
4,909
9,788
5,004
5,458
3,679
3,831
5,222
4,475
4,112
4,254
4,867
4,895
4,8954,8674,2544,1124,4755,2223,8313,6795,4585,0049,7884,90917,41719,315116,28992,940139,36970,62372,25117,93116,2865,6724,2465,5211,5317121,0811,6362,1592,53827,19333,87944,61822,0480037,2030000
       Intangible Assets 
1,574
0
0
0
647
369
168,170
165,661
163,152
171,672
165,442
162,789
258,923
254,166
254,460
249,492
241,261
242,863
236,819
230,806
335,036
336,231
326,586
317,200
308,459
291,627
282,913
275,492
268,072
259,420
252,045
245,069
279,784
272,213
264,846
451,398
442,784
825,857
801,923
777,668
752,009
752,009777,668801,923825,857442,784451,398264,846272,213279,784245,069252,045259,420268,072275,492282,913291,627308,459317,200326,586336,231335,036230,806236,819242,863241,261249,492254,460254,166258,923162,789165,442171,672163,152165,661168,1703696470001,574
       Long-term Assets Other 
0
0
0
0
-647
5,271
2,661
1,935
1,582
1,579
1,579
1,580
6,000
8,661
11,861
11,862
3,287
3,393
3,394
3,394
6,105
7,036
6,539
8,357
8,260
8,262
8,759
9,462
7,270
14,258
13,395
12,750
12,977
42,233
42,362
40,657
32,305
32,559
35,403
20,018
20,892
20,89220,01835,40332,55932,30540,65742,36242,23312,97712,75013,39514,2587,2709,4628,7598,2628,2608,3576,5397,0366,1053,3943,3943,3933,28711,86211,8618,6616,0001,5801,5791,5791,5821,9352,6615,271-6470000
> Total Liabilities 
32,680
0
0
0
40,347
68,720
91,133
120,129
80,935
84,401
84,657
91,423
287,725
257,706
243,903
243,251
266,391
251,396
270,239
274,103
532,925
479,248
505,500
589,553
568,968
603,682
623,270
737,044
750,585
688,286
679,177
646,041
725,825
727,940
690,824
903,044
957,876
1,467,716
1,553,612
1,573,522
1,612,607
1,612,6071,573,5221,553,6121,467,716957,876903,044690,824727,940725,825646,041679,177688,286750,585737,044623,270603,682568,968589,553505,500479,248532,925274,103270,239251,396266,391243,251243,903257,706287,72591,42384,65784,40180,935120,12991,13368,72040,34700032,680
   > Total Current Liabilities 
29,322
0
0
0
901
53,617
60,806
89,838
59,506
52,545
56,727
65,329
131,941
104,439
101,760
105,467
132,699
116,935
136,187
139,411
146,760
39,007
172,873
259,851
192,769
236,251
73,691
365,496
401,779
414,508
403,268
367,198
445,493
382,465
342,842
382,022
433,442
51,012
540,898
615,294
674,242
674,242615,294540,89851,012433,442382,022342,842382,465445,493367,198403,268414,508401,779365,49673,691236,251192,769259,851172,87339,007146,760139,411136,187116,935132,699105,467101,760104,439131,94165,32956,72752,54559,50689,83860,80653,61790100029,322
       Short-term Debt 
0
0
0
0
0
11,763
20,091
0
0
0
0
0
120,283
120,706
120,935
121,164
121,394
6,699
9,466
10,338
-122,596
3,439
4,649
5,390
6,269
5,785
7,474
7,438
33,914
34,145
33,920
33,434
7,069
6,445
6,389
7,053
7,122
4,608
6,218
13,957
9,738
9,73813,9576,2184,6087,1227,0536,3896,4457,06933,43433,92034,14533,9147,4387,4745,7856,2695,3904,6493,439-122,59610,3389,4666,699121,394121,164120,935120,706120,2830000020,09111,76300000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
120,283
120,706
120,935
121,164
121,394
121,623
121,853
0
0
3,439
0
0
0
0
0
0
26,557
26,606
26,655
26,704
0
0
0
0
0
0
0
991
0
0991000000026,70426,65526,60626,5570000003,43900121,853121,623121,394121,164120,935120,706120,283000000000000
       Accounts payable 
1,976
0
0
0
7,694
14,016
13,530
12,642
16,699
17,042
12,375
14,486
43,892
39,613
26,280
27,292
42,930
22,445
34,258
30,535
146,760
39,007
28,758
120,024
37,488
80,035
73,691
32,177
32,068
78,574
39,879
37,785
96,084
64,036
96,565
61,863
57,174
51,012
76,953
51,776
48,246
48,24651,77676,95351,01257,17461,86396,56564,03696,08437,78539,87978,57432,06832,17773,69180,03537,488120,02428,75839,007146,76030,53534,25822,44542,93027,29226,28039,61343,89214,48612,37517,04216,69912,64213,53014,0167,6940001,976
       Other Current Liabilities 
27,346
0
0
0
901
1,077
94
43,730
27,972
17,174
25,504
33,126
67,568
39,313
47,706
52,081
64,962
61,162
72,111
86,516
102,012
-25,759
112,543
111,736
129,184
133,408
-20,721
313,422
321,470
288,422
316,296
282,194
330,396
298,696
231,177
305,582
363,388
-11,677
450,777
543,798
610,282
610,282543,798450,777-11,677363,388305,582231,177298,696330,396282,194316,296288,422321,470313,422-20,721133,408129,184111,736112,543-25,759102,01286,51672,11161,16264,96252,08147,70639,31367,56833,12625,50417,17427,97243,730941,07790100027,346
   > Long-term Liabilities 
0
0
0
0
40,347
15,103
30,327
30,291
21,429
28,256
27,930
26,094
120,283
153,267
142,143
121,164
121,394
121,623
121,853
122,082
386,165
440,241
332,627
329,702
376,199
367,431
549,579
371,548
348,806
273,778
275,909
278,843
280,332
345,475
347,982
521,022
524,434
1,246,079
839,885
958,228
938,365
938,365958,228839,8851,246,079524,434521,022347,982345,475280,332278,843275,909273,778348,806371,548549,579367,431376,199329,702332,627440,241386,165122,082121,853121,623121,394121,164142,143153,267120,28326,09427,93028,25621,42930,29130,32715,10340,3470000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
120,283
120,706
120,935
121,164
121,394
121,623
121,853
122,082
221,041
223,320
225,642
227,996
293,667
296,676
299,746
285,213
263,343
202,132
206,550
211,063
215,676
282,598
283,138
412,444
412,986
632,277
633,013
599,947
0
0599,947633,013632,277412,986412,444283,138282,598215,676211,063206,550202,132263,343285,213299,746296,676293,667227,996225,642223,320221,041122,082121,853121,623121,394121,164120,935120,706120,283000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
-11,763
-20,091
0
0
0
0
0
-120,283
-120,706
-120,935
-121,164
-121,394
-6,699
-9,466
-10,338
122,596
57,197
70,796
70,560
68,858
60,961
66,975
64,738
35,969
33,686
31,963
30,579
57,722
56,354
58,581
57,840
56,010
54,274
56,576
38,659
38,009
38,00938,65956,57654,27456,01057,84058,58156,35457,72230,57931,96333,68635,96964,73866,97560,96168,85870,56070,79657,197122,596-10,338-9,466-6,699-121,394-121,164-120,935-120,706-120,28300000-20,091-11,76300000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
170,625
172,829
0
0
00172,829170,6250000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
67
111
7,927
7,972
7,997
14,655
14,091
10,024
9,982
9,861
11,368
10,666
10,885
17,090
67,687
81,219
77,113
80,590
68,625
77,076
84,945
84,735
70,561
9,784
66,757
63,253
61,353
63,200
104,970
106,704
170,881
172,983
3,978
3,637
3,6373,978172,983170,881106,704104,97063,20061,35363,25366,7579,78470,56184,73584,94577,07668,62580,59077,11381,21967,68717,09010,88510,66611,3689,8619,98210,02414,09114,6557,9977,9727,927111670000000
       Deferred Long Term Liability 
0
0
0
0
21,318
0
30,327
30,224
21,318
20,329
19,958
18,097
20,846
18,470
11,184
6,638
2,437
1,470
1,533
1,725
25,438
24,566
25,766
24,593
1,942
2,130
1,326
1,390
728
1,085
22,367
1,023
1,403
1,524
1,644
3,608
4,744
36,284
33,889
13,413
0
013,41333,88936,2844,7443,6081,6441,5241,4031,02322,3671,0857281,3901,3262,1301,94224,59325,76624,56625,4381,7251,5331,4702,4376,63811,18418,47020,84618,09719,95820,32921,31830,22430,327021,3180000
> Total Stockholder Equity
69,295
0
0
0
-2,070
7,714
654,210
646,666
649,341
541,524
537,728
562,228
702,526
750,471
859,769
1,019,847
1,010,879
1,043,142
1,041,233
1,038,565
1,143,824
1,100,026
1,130,678
1,108,460
922,358
848,072
646,864
629,818
619,600
617,298
614,190
607,484
693,633
611,209
613,088
856,138
859,417
1,121,743
1,093,219
1,096,093
1,067,701
1,067,7011,096,0931,093,2191,121,743859,417856,138613,088611,209693,633607,484614,190617,298619,600629,818646,864848,072922,3581,108,4601,130,6781,100,0261,143,8241,038,5651,041,2331,043,1421,010,8791,019,847859,769750,471702,526562,228537,728541,524649,341646,666654,2107,714-2,07000069,295
   Common Stock
0
0
0
0
1
0
590
590
590
601
601
601
659
679
685
774
774
779
784
792
823
825
845
845
846
855
855
858
859
868
872
874
908
916
916
1,012
1,015
170,625
172,829
1,148
1,154
1,1541,148172,829170,6251,0151,012916916908874872868859858855855846845845825823792784779774774685679659601601601590590590010000
   Retained Earnings Total Equity
0
0
0
0
0
0
322,787
310,807
306,688
183,876
175,232
164,024
146,617
128,605
111,699
99,111
85,952
89,041
79,125
66,696
50,009
3,270
-28,345
-53,866
-251,962
-333,684
-537,205
-574,553
-589,178
-598,985
-608,092
-621,132
-626,779
-592,340
-596,928
-594,805
-606,154
-626,136
-660,459
0
0
00-660,459-626,136-606,154-594,805-596,928-592,340-626,779-621,132-608,092-598,985-589,178-574,553-537,205-333,684-251,962-53,866-28,3453,27050,00966,69679,12589,04185,95299,111111,699128,605146,617164,024175,232183,876306,688310,807322,787000000
   Accumulated Other Comprehensive Income -1,257-1,265-1,114-1,122-1,178-1,044-782-494-362-363-367-309-278-320-391-387-234-215-147-158-182-264-148-18,023-14,458-11,279-8,945-7,017-5,236-3,647-2,723-1,935-1,233-701-154-5,169-3,9840000
   Capital Surplus 
0
0
0
0
0
0
330,833
335,269
342,063
357,047
361,895
397,603
555,250
621,187
747,385
919,962
924,153
953,322
961,472
971,341
1,093,174
1,096,089
1,158,325
1,161,696
1,173,708
1,180,288
1,183,605
1,224,956
1,229,320
1,236,847
1,242,900
1,249,228
1,340,989
1,224,250
1,231,005
1,472,098
1,486,857
1,768,999
1,774,784
1,803,116
0
01,803,1161,774,7841,768,9991,486,8571,472,0981,231,0051,224,2501,340,9891,249,2281,242,9001,236,8471,229,3201,224,9561,183,6051,180,2881,173,7081,161,6961,158,3251,096,0891,093,174971,341961,472953,322924,153919,962747,385621,187555,250397,603361,895357,047342,063335,269330,833000000
   Treasury Stock000000-21,123-21,123-21,123-21,123-21,123-21,123-21,123-21,123000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
27,717
5,169
-708,850
-720,211
343,296
358,982
364,618
401,250
560,486
628,204
756,330
931,241
938,611
953,322
961,472
971,341
1,093,174
1,096,089
1,158,325
1,161,696
1,173,708
1,180,288
1,183,605
1,203,833
1,208,197
1,215,724
1,221,777
1,228,105
1,319,866
1,203,127
1,209,882
1,450,975
1,465,734
1,407,751
921,504
1,096,093
1,608,571
1,608,5711,096,093921,5041,407,7511,465,7341,450,9751,209,8821,203,1271,319,8661,228,1051,221,7771,215,7241,208,1971,203,8331,183,6051,180,2881,173,7081,161,6961,158,3251,096,0891,093,174971,341961,472953,322938,611931,241756,330628,204560,486401,250364,618358,982343,296-720,211-708,8505,16927,7170000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,963,896
Cost of Revenue-1,503,426
Gross Profit460,470460,470
 
Operating Income (+$)
Gross Profit460,470
Operating Expense-481,525
Operating Income-71,211-21,055
 
Operating Expense (+$)
Research Development26,700
Selling General Administrative358,110
Selling And Marketing Expenses0
Operating Expense481,525384,810
 
Net Interest Income (+$)
Interest Income5,256
Interest Expense-54,205
Other Finance Cost-0
Net Interest Income-48,949
 
Pretax Income (+$)
Operating Income-71,211
Net Interest Income-48,949
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-202,40561,190
EBIT - interestExpense = -131,239
-202,405
-58,835
Interest Expense54,205
Earnings Before Interest and Taxes (EBIT)-77,034-148,200
Earnings Before Interest and Taxes (EBITDA)46,381
 
After tax Income (+$)
Income Before Tax-202,405
Tax Provision--89,365
Net Income From Continuing Ops-113,040-113,040
Net Income-113,040
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,984,951
Total Other Income/Expenses Net-132,40148,949
 

Technical Analysis of Evolent
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Evolent. The general trend of Evolent is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Evolent's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Evolent Health Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 28.82 < 29.09 < 29.46.

The bearish price targets are: 25.00 > 23.33 > 23.10.

Tweet this
Evolent Health Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Evolent Health Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Evolent Health Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Evolent Health Inc. The current macd is -0.75387174.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Evolent price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Evolent. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Evolent price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Evolent Health Inc Daily Moving Average Convergence/Divergence (MACD) ChartEvolent Health Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Evolent Health Inc. The current adx is 18.98.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Evolent shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Evolent Health Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Evolent Health Inc. The current sar is 30.78.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Evolent Health Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Evolent Health Inc. The current rsi is 30.47. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Evolent Health Inc Daily Relative Strength Index (RSI) ChartEvolent Health Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Evolent Health Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Evolent price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Evolent Health Inc Daily Stochastic Oscillator ChartEvolent Health Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Evolent Health Inc. The current cci is -196.74572559.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Evolent Health Inc Daily Commodity Channel Index (CCI) ChartEvolent Health Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Evolent Health Inc. The current cmo is -49.19720397.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Evolent Health Inc Daily Chande Momentum Oscillator (CMO) ChartEvolent Health Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Evolent Health Inc. The current willr is -94.80519481.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Evolent Health Inc Daily Williams %R ChartEvolent Health Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Evolent Health Inc.

Evolent Health Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Evolent Health Inc. The current atr is 0.94174032.

Evolent Health Inc Daily Average True Range (ATR) ChartEvolent Health Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Evolent Health Inc. The current obv is 10,547,899.

Evolent Health Inc Daily On-Balance Volume (OBV) ChartEvolent Health Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Evolent Health Inc. The current mfi is 38.43.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Evolent Health Inc Daily Money Flow Index (MFI) ChartEvolent Health Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Evolent Health Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-27MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Evolent Health Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Evolent Health Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.474
Ma 20Greater thanMa 5030.247
Ma 50Greater thanMa 10031.802
Ma 100Greater thanMa 20031.239
OpenGreater thanClose28.970
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Evolent with someone you think should read this too:
  • Are you bullish or bearish on Evolent? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Evolent? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Evolent Health Inc

I send you an email if I find something interesting about Evolent Health Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Evolent Health Inc.

Receive notifications about Evolent Health Inc in your mailbox!